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Abstract
Motivation: Metabolic flux balance analyses are a standard tool in analysing metabolic reaction rates compatible with measurements, steady-
state and the metabolic reaction network stoichiometry. Flux analysis methods commonly place unrealistic assumptions on fluxes due to the
convenience of formulating the problem as a linear programming model, and most methods ignore the notable uncertainty in flux estimates.
Results: We introduce a novel paradigm of Bayesian metabolic flux analysis that models the reactions of the whole genome-scale cellular system
in probabilistic terms, and can infer the full flux vector distribution of genome-scale metabolic systems based on exchange and intracellular (e.g.
13C) flux measurements, steady-state assumptions, and target function assumptions. The Bayesian model couples all fluxes jointly together in a
simple truncated multivariate posterior distribution, which reveals informative flux couplings. Our model is a plug-in replacement to conventional
metabolic balance methods, such as flux balance analysis (FBA). Our experiments indicate that we can characterise the genome-scale flux
covariances, reveal flux couplings, and determine more intracellular unobserved fluxes in C. acetobutylicum from 13C data than flux variability
analysis.
Availability: The COBRA compatible software is available at github.com/markusheinonen/bamfa
Contact: markus.o.heinonen@aalto.fi
1 Introduction
Metabolic modelling considers networks of up to thousands of chem-
ical reactions that transform metabolite molecules within cellular or-
ganisms (Palsson, 2015). The key problem of metabolism is esti-
mation of the reaction rates, or fluxes, of the system of the highly
interdependent intracellular fluxes from measurements of few ex-
change fluxes that transfer nutrients or products between the external
medium and the cell.
The dominant approach to flux estimation is the celebrated Flux
Balance Analysis (FBA) framework that finds reaction rates that
maximise prespecified cellular growth function (Feist and Palsson,
2010), while assuming the cell is in a steady-state, where concen-
trations of intracellular metabolites do not change (Almaas et al.,
2004). The FBA problem can be casted as a convenient and compu-
tationally efficient linear programming problem of solving a system of
linear steady-state constraints while maximising a linear growth tar-
get (Orth et al., 2010), and where flux measurements can be encoded
as constraints to the fluxes (Carreira et al., 2014). FBA is commonly
used to characterise intra-cellular fluxes in various simulated target
conditions (Mo et al., 2010). In metabolic flux analysis (MFA) values
of unknown fluxes are directly estimated based on measurements of
some determined fluxes without explicit maximal growth assumption
(Kim et al., 2008). In both approaches a point estimate for up to
thousands of highly interdependent fluxes are determined (Bordbar
et al., 2014).
The standard metabolic analyses suffer from several approxima-
tions that warrant careful methodological protocol to achieve biolog-
ically meaningful results. First, the exact steady-state constraint is
an unrealistic assumption since metabolites can accumulate or deplete
(Pakula et al., 2016). Second, in FBA maximal growth is assumed,
while it only holds at the highest growth phase in practise. Finally,
due to a large number of metabolic reactions and limited number of
experimental data, flux point estimates commonly used in the field
completely ignore the notable uncertainty involved in FBA and MFA
solutions. The flux variances are key in characterizing metabolic sys-
tems and uncertainties emerging from the use of insufficient and noisy
data.
Numerous separate extensions to flux analysis have been intro-
duced to alleviate these limitations. The robust FBA framework con-
siders the effect of measurement uncertainties to the maximal growth
(Zavlanos and Julius, 2011). The steady-state assumption was re-
cently relaxed by the RAMP model (MacGillivray et al., 2017). In
contrast to point flux estimates of FBA and MFA, the flux variabil-
ity analysis (FVA) characterises the sensitivity of the target func-
tion to independent flux perturbations, resulting in upper and lower
bounds around the FBA solution (Mahadevan and Schilling, 2003;
Gudmundsson and Thiele, 2010). In principal flux mode analysis the
eigenvectors of steady-state flux cone characterise the flux variability
(Bhadra et al., 2018). Alternatively the solution space of the fluxes
can be sampled (Schellenberger et al., 2010) by considering only opti-
mal fluxes from border of the flux hypercone (Bordel et al., 2010) or
by sampling also inoptimal fluxes from the inside the hypercone (Mo
et al., 2010; Saa and Nielsen, 2016). The sampling methods use the
’Hit-and-Run’ (Smith, 1984) or ’Artificially Centered Hit-and-Run’
(Kaufman and Smith, 1998) algorithms to cope with the large flux
space. A related approach uses possibility calculus (Dubois et al.,
1996) to iteratively refine the estimate of possible and impossible
flux states (Llaneras et al., 2009).
There is a distinct lack of approaching metabolism with statisti-
cal modelling. The sole statistical approach for flux analysis remains
the Metabolica framework that proposed modelling distributions of
fluxes of skeletal muscle metabolism (Heino et al., 2007, 2010), but did
not include modelling of maximal growths or genome-scale metabolic
models. Bayesian methods have also been developed for 13C labeling
data (Kadirkamanathan et al., 2006; Theorell et al., 2017) by assum-
ing fixed steady-state and without incorporating any target growth
condition.
In this paper we tackle all three limitations simultaneously by intro-
ducing a novel paradigm of Bayesian metabolic flux analysis where
the genome-scale, interdependent flux vector distributions are esti-
mated. In Bayesian formalism prior distributions on flux random
variables are determined, and subsequently updated by incorporat-
ing the measurement information, resulting in posterior flux distribu-
tions. We place priors on flux distributions, and estimate posterior
distributions that characterise and quantify the probability of all flux
states that are compatible with flux measurements, steady-state as-
sumption and stoichiometry. Our model can reveal flux dependencies
in explicit form, and characterise the full space of flux states in prin-
cipled fashion. The Bayesian flux analysis can be used as a drop-in
replacement to standard FBA, MFA, FVA and sampling methods.
We provide public implementation of the Bayesian flux analysis using
the standard COBRA framework (Becker et al., 2007; Schellenberger
et al., 2011).
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2 Methods
The goal of this paper is a probabilistic formulation of static steady-
state metabolic systems that can be applied to whole genome
metabolic flux analysis (MFA), flux balance analysis (FBA) and flux
variability analysis (FVA). We propose the Bayesian method as a
direct replacement to these classic FBA, MFA and FVA tools. We
start by assuming a metabolic system of M metabolites and N re-
actions has been characterised by a constant stoichiometric matrix
S ∈ ZM×N , where the rows denote metabolite participations in all re-
actions, while the columns denote reactants and products of metabo-
lites by individual reactions. The flux vector v = (v1, . . . , vN )
T ∈ RN
denotes the reaction rates of the system. The steady-state equation
can be stated as
Sv = x˙ = 0,
which encodes that metabolite concentration changes x˙ ∈ RM are
zero and hence the metabolite concentrations x ∈ RM do not change.
Throughout the paper we assume a subset of fluxes have been ob-
served or determined (for instance, some of the exchange fluxes),
while the remaining fluxes are unknown. Our goal is to infer the dis-
tribution of all unknown fluxes given the observed fluxes, the steady-
state constraints and the flux lower and upper bounds.
2.1 Bayesian metabolic model
We formulate a Bayesian flux model, which starts by assuming mul-
tivariate Gaussian priors for fluxes as
v|mv,σv ∼ N (mv,Σv),
with means mv ∈ RN and diagonal covariances Σv = diag(σ2v) =
diag(σ2v1 , . . . , σ
2
vN ). The prior means are set to zero, or to the clos-
est value to zero considering the flux upper and lower bounds. The
variances σvi are hyperparameters that characterise the a priori val-
ues the flux can take. The prior distribution converges towards an
uninformative uniform prior as the prior variances increase.
We assume a Gaussian prior also for the metabolite changes
x˙|mx˙,σx˙ ∼ N (mx˙,Σx˙),
where mx˙ ∈ RM are the a priori mean accumulations or depletions
of metabolite species. The diagonal covariances Σx˙ = diag(σ
2
x˙) =
diag(σ2x˙1 , . . . , σ
2
x˙M
) encode the variances around prior metabolite
changes. In strict steady-state, the prior for metabolite change be-
comes Dirac’s delta function at zero. By increasing the variances σ2x˙
we can relax the steady-state assumption on individual metabolites,
and encode allowance for accumulations or depletions of them.
The joint distribution of fluxes v and metabolite changes x˙ can
now be stated as a joint multivariate Gaussian distribution[
v
x˙
]
=
[
v
Sv
]
∼ N
([
mv
Smv
]
,
[
Σv ΣvS
T
SΣv SΣvS
T
])
,
that encodes the exact1 relation Sv = x˙. The conditional distribution
of fluxes given a specific realisation of metabolite changes x˙ (e.g. 0)
is then from standard Gaussian identities
v|x˙ ∼ N
(
mv + ΣvS
T (SΣvS
T )−1(x˙− Smv),
Σv − ΣvST (SΣvST )−1SΣv
)
∼ N (mv +A(x˙− Smv),Σv −ASΣv)
where A = ΣvS
T (SΣvS
T )−1. Since we do not in general have access
to exact metabolite change values x˙, we marginalise the conditional
flux distribution over the change prior distribution p(x˙) resulting in
p(v|σv,σx˙) =
∫
p(v|x˙)p(x˙)dx˙
= N (v|µ, C), (1)
where µ = mv +A(mx˙ − Smv) and C = Σv −ASΣv +AΣx˙AT .
1We add small numerical tolerance κI within the inverse to ensure invertibility
of the matrix.
2.2 Conditioning the model with observations
Assume we have access to noisy observations yo = vo + ε from a
subset of observed fluxes vo ⊂ v. The observations can be em-
pirical measurements, 13C flux estimations, or flux hypotheses de-
termined by the user. We assume independent additive Gaussian
noise εi ∼ N (0, ω2i ) with variances collected in a matrix Ωo =
diag(ω21 , . . . , ω
2
Nobs
), and hence the likelihood of observed fluxes is
p(yo|vo,ωo) = N (yo|vo,Ωo).
The joint distribution of all fluxes v and noisy flux observations
yo is now[
v
vo + ε
]
=
[
v
yo
]
∼ N
([
µ
µo
]
,
[
CNN CNo
CoN Coo + Ωo
])
,
which gives a conditional distribution of all fluxes given the observa-
tions as
v|yo ∼ N (µ+ CNoC−1y (yo − µo), C − CNoC−1y CoN ), (2)
where Cy = Coo+Ωo is the noisy covariance, CNN is the full (N×N)
covariance matrix, CNo = C
T
oN is the (Nobs × N) covariance matrix
between observed fluxes and all fluxes, and Coo is the (Nobs ×Nobs)
covariance matrix between observed fluxes. Note that observed fluxes
are in both v and in vo. Note also that the model works with no
observations at all as the conditional distribution in Eq. (2) reduces
back to the prior in Eq. (1).
Finally, we add the flux upper and lower bounds by truncating
the distribution with the known flux lower lb and upper ub bounds
resulting in the final truncated normal flux posterior
v|yo ∼ T N (µ+ CNoC−1y (yo − µo), C − CNoC−1y CoN , lb, ub),
The posterior encodes the distribution of bounded fluxes that are
compatible with the flux observations, flux priors, and where steady-
state applies according to the tolerances determined by the steady-
state prior means mx˙ and variances σ
2
x˙.
The derived flux posterior is an unimodal truncated multivariate
normal (TMVN) distribution where flux dependencies are represented
through the covariance matrix C, which encodes all flux relation-
ships with high rank. The flux posterior as a whole characterises
the distribution of all valid flux vectors. The main characterisations
of interest are the individual flux distributions (the marginals) and
flux combination distributions (multi-variate marginals). Marginals
of TMVN’s are not analytically tractable, nor are they TMVN dis-
tributions (Horrace, 2005). We resort to MCMC sampling from the
TMVN flux distribution to reveal individual flux, flux pair or flux
group distributions.
2.3 Gibbs sampling truncated MVN’s
A recent review summarises sampling approaches for Truncated
MVN’s (Altmann et al., 2014). The conditionals of TMVN’s are still
TMVNs (Horrace, 2005), which has lead to many Gibbs based sam-
plers (Geweke, 1991; Kotecha and Djuric, 1999; Horrace, 2005; Emery
et al., 2014; Li and Ghosh, 2015), while also HMC samplers (Pakman
and Paninski, 2014) have been proposed, while elliptical slice sam-
plers would also fit well to the problem (Murray et al., 2010). We
experimented with the three main approaches, and found out that
Gibbs sampling has consistently the best performance in genome-
scale metabolic models up to 4000 fluxes (data not shown). In the
remainder of the paper we apply Gibbs sampling.
To sample the distribution v ∼ T N (µ, C, lb, ub) we begin by
transforming it into whitened domain by Cholesky decomposition
C = LLT with transformed fluxes v˜ = L−1(v−µ) with white distri-
bution v˜ ∼ T N (0, I,a,b), where a = lb−Lµ and b = ub−Lµ. We
sample from the univariate conditional distributions
v˜i|v˜−i ∼ T N (0, 1, a(v˜−i), b(v˜−i)), (3)
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Runtime
Organism Model N M thin 100 thin 1000
E. coli core 95 72 2 min 20 min
E. coli iJR904 1075 761 2 hr 1 d 9 hr
E. coli iAF1260 2382 1668 7 hr 4 d 12 hr
E. coli iJO1366 2583 1805 9 hr 4 d 16 hr
B. subtilis iYO844 1250 992 3 hr 1 d 11 hr
C. acetobutylicum Wallenius (2013) 592 444 23 min 3 hr
S. cerevisiae iMM904 1577 1226 3 min 2 d
S. cerevisiae 7.6 3493 2220 10 hr 5 d 15 hr
T. reesei CORECO 4008 3292 8 hr 4 d 15 hr
Table 1: Metabolic models analysed by Bayesian flux analysis by sampling
500 samples from the flux posteriors. The runtime is shown for thinning
rate 100 and 1000.
which is a standard Normal with bounds in the white domain are
(We refer to Li and Ghosh (2015) for detailed explanation):
a(v˜−i) = max
{
max
j:Lji>0
aj − Lj,−iv˜−i
Lji
, max
j:Lji<0
bj − lj,−iv˜−i
Lji
}
b(v˜−i) = max
{
min
j:Lji>0
bj − lj,−iv˜−i
Lji
, min
j:Lji<0
aj − lj,−iv˜−i
Lji
}
.
The bounds are functions of the remaining (whitened) fluxes v˜−i and
need to be updated after each change to flux values. We iteratively
update each whitened flux v˜i by sampling a new value from the con-
ditional distribution v˜i|v˜−i with the minimax tilting method (Botev,
2016), which we found out to outperform the alternative Chopin’s al-
gorithm (Chopin, 2011). Finally, we transform the whitened variables
back into original domain by v = Lv˜ + µ.
We notice that the method of Li and Ghosh (2015) can be further
optimised by running multiple chains in parallel by considering a flux
sample matrix V˜ = (v˜1, . . . , v˜Nc) containing whitened flux vector
chains v˜c. The bound function is then represented as
a(V˜−i) = max
{
max
j:Lji>0
a− L−iV˜−i
Lji
, max
j:Lji<0
b− L−iV˜−i
Lji
}
b(V˜−i) = max
{
min
j:Lji>0
b− L−iV˜−i
Lji
, min
j:Lji<0
a− L−iV˜−i
Lji
}
,
where V˜−i is the sample matrix V˜ without the i’th row, L:,−i is the
Cholesky matrix without the i’th column. By sampling several chains
in parallel with one CPU node we can utilise the full bandwidth of
the CPU. This is especially useful for Gibbs sampling.
2.4 Sampling the flux posterior
We set the initial flux vector v(0) = vMAP = arg maxv p(v) to the
maximum a posteriori (MAP) of the truncated normal distribution,
which we compute using quadratic programming. The truncated nor-
mal distribution is unimodal, and hence we begin sampling from the
mode of the distribution providing efficient optimization.
The fluxes can be arranged into distinct bounded fluxes vb and un-
bounded fluxes vu, where v = (vb,vu)
T . The conditional distribution
of a truncated normal is still a truncated normal (Horrace, 2005). We
only need to sample the bounded fluxes vb with Gibbs MCMC, and
afterwards the distribution of unbounded fluxes vu conditioned on
the bounded flux samples vb can be drawn from untruncated normal
as
vu|vb ∼ N (µu + CubC−1bb (vb − µb), Cuu − CubC−1bb Cbu),
where we arrange µ = (µb,µu)
T and C =
(
Cbb Cbu
Cub Cuu
)
.
We implement the MCMC sampling in Matlab. We run multiple
independent Markov chains in a vectorised form. By default we run
Nc = 10 chains of Ns = 500 flux samples for a total of 5000 flux
vector samples. We use thinning and only accept every Nt = 100’th
flux sample. The MCMC chains have converged if successive samples
are uncorrelated, chains are indistinguishable and have effectively for-
gotten the initial value. Convergent chains indicate that the MCMC
Figure 1: The effective number of independent simulation draws for a
individual fluxes for a subset of models from Bayesian flux analysis with
different thinning parameters. The x-axis corresponds to individual fluxes
sorted based on the effective number of samples.
sampler has characterised the whole flux posterior. We use potential
scale reduction factor Rˆ to approximate convergence (Gelman and
Rubin, 1992). An optimal value of Rˆ = 1 indicates convergence,
while values Rˆ < 1.1 are considered sufficient for convergence. We
also compute the effective number of samples Neff per flux (Gelman
et al., 2013).
We assume that flux means mv are fixed to either zero or the lower
bound of each respective flux. The model has then two main hyper-
parameters σv and σx˙ that affect the posterior. The σx˙ determines
how much the mass balance can be relaxed, and can be set according
to the prior knowledge of the modeller. To enforce mass balance, a
small value such as σx˙ = 0.001 should be chosen. The prior flux
variance σ2v determines how much fluxes are driven towards zero a
priori, but also should be set to sufficiently high value not to exclude
possibly high fluxes. In practise we set the variance σ2vi = 100
2 for
all fluxes vi.
2.5 Sampling FBA solutions
The presented Bayesian model is a metabolic flux analysis (MFA)
model designed to characterise the global flux configurations v ∼
p(v|yobs) compatible with mass balance assumption, observations,
and bounds. The method can as well be applied as an flux balance
analysis (FBA) method, where a target function – such as biomass
reaction – is maximised. For FBA mode we first find the standard
FBA solution target flux vFBAtarget with linear programming, and encode
it as a flux observation ytarget ± ω2c , where the variance determines
how closely we sample from the maximal target. By default, we set
the standard deviation to 0.1% of the target flux. To run maximum
growth Bayesian FBA we would set an observation for the biomass
pseudoreaction to the classical FBA maximum growth value and con-
dition the model with the pseudo-measurement as in Sec. 2.2.
3 Results
We first perform in silico experiments to highlight the capabilities of
the Bayesian FBA and MFA models in Sections 3.1–3.3. Our goal
is to compare the computational approach against the conventional
FBA and FVA methods, and to showcase the method’s in silico per-
formance in various metabolic models. The main experiment of this
paper is application of the Bayesian flux analysis to the 13C analysis
of the C. acetobutylicum in Section 3.4, where we can elucidate fluxes
on a genome-scale from a small set of intracellular flux measurements.
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Figure 2: Posterior flux distributions of E. coli core model. The blue
color indicates fluxes in 50% growth, the green color maximal growth,
the red color maximal growth with 9 exchange fluxes specified, and the
conventional FBA solution is a black line.
3.1 In silico metabolic models
Table 1 indicates the stoichiometric models that were considered.
We considered four organisms, seven genome-scale metabolic mod-
els and one core model. All models were downloaded from the BiGG
database2. For all models we run the Bayesian model in FBA mode –
by specifying a growth target – with standard exchange flux measure-
ments included as bounds. We sampled 10 chains of 500 flux vector
samples from the full space containing all intracellular and extracel-
lular fluxes. These 5000 flux vectors represent all possible flux con-
figurations compatible with the experimental setting. The sampling
thinning parameter determines how uncorrelated successive MCMC
samples are. We applied thinning values of 100 and 1000, with linear
effect on the running time.
The effective number of independent simulation draws for all mod-
els from Bayesian flux analysis with different thinning parameter are
shown in Figure 1 using the potential scale reduction factor. The
x-axis corresponds to individual fluxes sorted based on the effective
number of samples. The number of reactions is different for different
models. In all cases majority of the fluxes have over 100 effective
number of independent samples, which indicates that the samples
represent the flux posterior well. A minority of the fluxes have low
effective sample sizes. These are usually central branching fluxes that
are highly dependent across the genome-scale metabolism, and hence
converge slowly. The thinning parameter has a large effect on some
models (core, iJR904, iAF1260, iJO1366) whereas for some other
models there are not much change (CORECO, iYO844, iMM904,
7.6).
3.2 Bayesian FBA and MFA
We illustrate the characteristics of the Bayesian model using E. coli
central carbon metabolism model3. The model contains 95 fluxes
and 72 metabolites. It should be noted that the model was not fur-
ther constrained and do not represent the native E. coli strain as
such, while it allows e.g. carbon fixation. The model was rather
used to theoretically compare our modelling approach to conventional
FBA methodology. The conventional FBA solution achieves a growth
flux vFBAgrowth ≈ 0.873 by limiting the glucose exchange flux with a
lbglc = −10. We consider three cases of Bayesian analysis: (i) 50%
growth by defining only the biomass flux observation 0.436± 0.0043,
(ii) maximal growth scenario by defining the biomass flux observation
0.873±0.0087, and (iii) maximal growth with additional observations
for 9 key exchange fluxes: GLC, O2, CO2, H2O, H+, HPO4, SO4, NH4 and
ethanol that were all set to their conventional FBA solutions with
2http://bigg.ucsd.edu
3BiGG model e coli core
Figure 3: Examples of flux covariance distributions of E. coli core net-
work. Blue points represent 50% growth, green points maximal growth,
red points maximal growth with 9 exchange fluxes specified, and the con-
ventional FBA solution is a black dot. Scatter plots represent pair-wise (2-
dimensional) marginal posterior distributions as obtained from the MCMC
samples.
a standard deviations of 0.01. In all three experiments the remain-
ing fluxes were free with only a prior distribution with a standard
deviation of 100 specified. We defined a nearly strict steady-state
by defining σx˙ = 0.01. We sample a total of 5000 flux vectors with
the Gibbs sampler using 10 chains and 500 samples each. We use
1-dimensional kernel density estimates as proxies of marginal flux
posterior distributions. The small jaggedness of the distributions are
an artefact from the MCMC sampling. By considering longer chains
these would eventually smoothen out.
Figure 2 shows the flux distributions of 30 fluxes. The blue color
indicates the 50% growth flux distributions, the green color the max-
imal growth distributions, the red color maximal growth with ex-
change fluxes specified, and the conventional FBA is shown with
a black line. The Bayesian distributions represent the space of all
allowed steady-state flux configurations given the observations and
target function. Figure 2 shows that maximal growth can still sup-
port a large variance in many fluxes, with the FBA point esti-
mate misleading by only considering one flux configuration. Simi-
larly to conventional FVA our approach elucidates directly the pos-
sible variance in a given flux. For instance, the pentose-phosphate
pathway flux G6PDH2r: D-Glucose 6-phosphate + NADP ⇔ 6-
Phosphogluconolactone + H+ + NADPH can vary between −8 and
−2 in maximal growth. The conventional FBA yields zero flux for
glyoxylate cycle flux MALS: Acetyl-CoA + Glyoxylate + H2O ⇒
CoA + H+ + Malate, while the flux space indicates that values up
to 4 are possible.
The red distributions indicate how the intracellular fluxes get more
and more specified as the model is better specified by inclusion of
exchange measurements. Variance of almost all fluxes reduces by
more than half. For instance, the flux FUM: Fumarate + H2O ⇔
Malate is specified to a range of [−5.1,−4.9] from a range of [−6.5, 4.4]
without exchange measurements.
The blue color indicates the cellular flux state when the cell is
only growing at 50% of the maximum growth rate. Most fluxes have
a higher variance in this scenario. Interestingly the glucose intake is
still kept at a relatively high rate. Instead of biomass production, the
excess carbon from glucose can be diverted to other carbon sinks, such
as formate and ethanol production. The ethanol and formate effluxes
can grow up to 3 and 15, respectively. The carbon dioxide exchange
decreases by over half into a range of [−15,−3] from maximal growth
exchange range of [−25,−23].
4
3.3 Flux couplings
The flux variations are in general not independent from each other.
To understand the intracellular flux space, we need to consider higher-
order flux dependencies. The flux sample covariances indicate flux
couplings, where the variation in one flux is constrained by other
fluxes. Figure 3 highlights 9 example flux pair patterns out of the
total of 95·942 = 4465 in the core model. Blue points represent 50%
growth, green points maximal growth, red points maximal growth
with 9 exchange fluxes specified, and the conventional FBA solution
is a black dot.
The flux covariations become consistently more constrained while
traversing from the loose 50% growth model (blue) towards 100%
maximal growth (green). By measuring the exchange fluxes (red),
we can already pinpoint most flux patterns very closely around the
theoretically optimal flux pattern as defined by the conventional FBA
(black).
Multiple patterns of covariation can be immediately identified.
There is an exact coupling between pentose-phosphate pathway re-
actions GND: 6-Phospho-D-gluconate + NADP ⇒ CO2 + NADPH
+ D-Ribulose 5-phosphate and TALA: Glyceraldehyde 3-phosphate
+ Sedoheptulose 7-phosphate ⇔ D-Erythrose 4-phosphate + D-
Fructose 6-phosphate, as expected from the stoichiometry. Glycol-
ysis related FBA: D-Fructose 1,6-bisphosphate ⇔ Dihydroxyacetone
phosphate + Glyceraldehyde 3-phosphate and pentose-phosphate
pathway related G6PDH2r have also a strong, but not exact, negative
correlation. The flux PGI: D-Glucose 6-phosphate ⇔ D-Fructose 6-
phosphate and carbon dioxide exchange have no correlation, but the
maximal growth still pinpoints to a carbon dioxide exchange value
of approximately −21. The dependency of glyoxylate cycle related
MALS and TCA cycle related SUCOAS: ATP + CoA + Succinate⇔
HPO−24 + ADP + Succinyl-CoA on maximal growth requirement can
be observed in Figure 3. Under maximal growth a negative correla-
tion between the two fluxes emerges. The conventional FBA solution
pinpoints an optimal values as zero MALS with SUCOAS around 5,
while the Bayesian model reveals that MALS can still have a flux
value of around 4 as long as SUCOAS tends towards 1.5 simultane-
ously.
The patterns of G6PDH2r and FBA and FUM indicate a linear
inequality for these fluxes. Especially with FUM this is natural since
the pentose-phosphate pathway flux G6PDH2r limits the TCA cycle
flux FUM. The same effect is also seen with G6PDH2r and ICDHyr:
Isocitrate + NADP ⇔ 2-Oxoglutarate + CO2 + NADPH, another
TCA cycle flux.
To get more insight into the biology behind the flux couplings, the
flux pair patterns can also be illustrated in the metabolic network
(Figure 5). Figure 5 shows the samples of the flux distributions for
several example pairs of reactions. These scatter plots indicate the
dependency of the flux configurations between two reactions across
the reaction. There is natural correlation between adjacent or subse-
quent fluxes but also correlation between fluxes in different pathways,
such as glycolysis and TCA cycle (See the SUCOAS and TKT1 pair).
3.4 Intracellular flux elucidation of C. aceto-
butylicum
We consider the results obtained from 13CMFA of Clostridium ace-
tobutylicum grown in chemostat, i.e. in continuous cultivation main-
taining steady-state, with reference condition, glucose limited con-
dition and butanol stimulus with the goal of inferring the internal
fluxes. We effectively repeat the study of Wallenius et al. (2016),
where FBA and FVA were performed and constrained on 12 intracel-
lular fluxes determined by 13CMFA and 7 exchange fluxes. The model
for Clostridium acetobutylicum consists of 451 metabolites and 604
reactions, and is given as an .xml file in the supplement of Wallenius
et al. (2016).
The data from different measurements in glucose limited condi-
tion are shown in Table 2. For the reference and the butanol stim-
ulated conditions, see Supplementary Tables 2 and 3. The inter-
nal fluxes are obtained from 13CMFA analysis, whereas the exchange
fluxes were measured by chromatographical methods or transferred
from the 13CMFA results. Flux values were normalized to the specific
growth rate which was given the value of 1, except for the reference
condition, the measured growth is 0.95. Exchange fluxes measured
from the cultivations were given to Bayesian MFA as mean vo and
standard deviations Ω0 = 0.05 ·vo and fluxes obtained from 13CMFA
were given as ranges. In all Bayesian MFA experiments, the steady
state relaxation was σx˙ = 0.01. Finally, 500 samples were drawn from
the posterior with thinning 1000.
To study the FBA’s, FVA’s and BMFA’s performance to predict
the measured distributions of metabolic fluxes, three sets of mod-
els were generated: (A) a model with reaction directions for the 12
13CMFA determined internal fluxes set according to the data (bounds
in table 2 ), (B) a set of 12 models where each reaction among 12
13CMFA determined internal fluxes is unconstrained at a time (the
reaction direction is still constrained) while the rest 11 fluxes are
constrained according to the measurements (leave-one-out), and (C)
a model with all 12 13CMFA determined internal fluxes constrained
to their measured values. In all three cases we constrain the model
with measured values for the 6 exchange reactions and the measured
growth. For the (B) set of models, we test how well we can predict
the 13CMFA determined flux interval for the leave-one-out reaction
by comparing the prediction with 13CMFA determined flux. For each
set of models, the standard MFA with Taxicab penalty, FVA, and
Bayesian MFA were performed. The MFA and FVA were performed
by The Cobra Toolbox’s optimizeCbModel and fluxVariability
functions by maximizing growth with the growth lower and upper
bounds set to the measured value 1.
We study how the flux variances from Bayesian MFA results de-
crease when adding 13CMFA constraints. The Figure 4 shows the
reduction of standard deviations of flux distributions of all fluxes of
C. acetobutylicum in glucose limited condition when all 12 13CMFA
constraints are added to the model (model set C). When adding the
13CMFA constraints, the variance of most unmeasured internal fluxes
decreases, demonstrating how Bayesian MFA propagates the infor-
mation about 12 measured fluxes to several tens of other internal
fluxes. The reduction of standard deviations of flux distributions for
the reference and butanol stimulated conditions are shown in Supple-
mentary Figures 2 and 3.
For the glucose limited experiment, the MFA, FVA and Bayesian
MFA results for model sets A, B and C are shown for 12 13CMFA
determined reactions in Figure 6. To quantify the performance of
FVA and Bayesian MFA to predict the 13CMFA measured range of
flux values, precision, recall and the F1 score were computed for each
reaction and model set. The F1 score values are shown in Table 2
as percentage and the precision and recall values are shown in the
Supplementary Table 1. From Table 2 it can be concluded that the
Bayesian MFA outperforms FVA for most of the reactions, especially
in the leave-one-out testing. In Figure 6, for the model set A, the
FVA gives a wide range of solutions whereas the distribution from
Bayesian MFA is narrower and closer to the true values for almost
Reaction KEGG ID Bounds Glucose limited
Exchange fluxes
†Glucose exchange C00031 ≤ 0 −73.3 ± 3.7
‡Acetate exchange C00033 0 ≤ [12.96 . . 13.016]
†Acetone exchange C00207 0 ≤ 12.5 ± 0.06
‡Butanol exchange C06142 0 ≤ [29.62 . . 30.67]
Butyrate exchange C00246 0 ≤ [0 . . 3.23]‡
†Ethanol exchange C00469 0 ≤ 6.13 ± 0.31
‡EPS production 0 ≤ [10.01 . . 10.26]
†Growth 0 ≤ 1.00 ± 0.05
F1 scores %
ex only LOO ex + 13C
FVA BMFA FVA BMFA FVA BMFA
Malate DHase R00342 [−112 . . −5.94] 19 7 65 19 68 23
3P-glycerate DHase R01513 0 ≤ [1.53 . . 4.85] 1 53 12 59 100 100
Acetaldehyde DHase R00228 [−27.4 . . 50.3] 8 56 12 73 95 92
Triosephosphate DHase R01061 0 ≤ [77.2 . . 132] 10 95 5 75 63 85
Acetolactate synthase R04672 [−95.2 . . 99.4] 17 67 17 68 68 68
Aspartate transaminase R00355 ≤ 0 [−8.95 . . −0.80] 1 32 14 29 69 69
5,10-CH=THF hydrolyase R01655 [−2.24 . . 0.05] 0 3 0 3 100 100
Malate hydrolyase R01082 ≤ 0 [−10.2 . . −0.78] 2 83 59 54 62 67
Ribulose-5P epimerase R01529 [−4.39 . . −1.27] 1 0 1 0 100 100
Pyruvate carboxylase R00344 0 ≤ [13.6 . . 119] 19 36 65 33 66 26
Carbonate hydrolyase R10092 [26.2 . . 75.7] 10 57 97 31 100 53
C-acetyl transferase R00212 0 ≤ [66.3 . . 154] 16 2 84 13 100 81
Average 9 41 36 38 83 72
Table 2: The 6 exchange flux, the growth and EPS production, and the 12
internal flux measurements. Measurements from the cultivations include
standard deviations, while fluxes determined by 13CMFA∗ are given as
a range. The unit used for the model fluxes is: mmol g−1(CDW). † :
measured by chromatographic methods, ‡ obtained from 13CMFA
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Figure 4: Global flux standard deviation reduction due to addition of twelve 13CMFA internal flux measurements in glucose limited condition. The green
points indicates the standard deviation of fluxes given only exchange measurements. The red points indicate the corresponding standard deviations after
inclusion of twelve 13CMFA intracellular flux measurements. The blue circles highlight the 13CMFA measured fluxes.
Figure 5: Pair-wise marginal posterior fluxes presented together the the metabolic network map. The visualized fluxes are highlighted. Blue points represent
flux values in 50% growth, green points in maximal growth, red points in maximal growth with 9 exchange fluxes specified, and the conventional FBA
solution is a black dot.
6
(a) Only exchange fluxes observed
(b) Exchange fluxes and leave-one-out internal fluxes observed
(c) Exchange and internal fluxes obtained from 13CMFA fluxes observed
Figure 6: For the glucose limited condition, flux distributions of the 12 internal fluxes predicted solely from exchange fluxes (a), and distributions after
seeing 13CMFA data in leave-one-out experiment (b) and after seeing all 12 internal reactions (c).
all reactions. Figure 6b shows the results for the model set B: for
reactions 3P-glycerate dehydrogenase, Acetaldehyde dehydrogenase,
Triosephosphate dehydrogenase and Acetolactate synthase the flux
distribution obtained by Bayesian MFA matches the test data bet-
ter. In Figure 6c the resulting flux ranges for FVA and Bayesian
MFA distributions are always within the true measured range, but
the Bayesian MFA captures the probability in the flux values. Similar
results are obtained for the butanol stimulated and reference condi-
tions (See Supplementary Tables 2 and 3 Supplementary Figures 4
and 5).
4 Discussion
The conventional FBA formalism is a powerful framework for flux
analysis that however assumes several unrealistic simplifying model
approximations. Several approaches from robust flux analysis and
sampling to flux variability analyses indicate the need to alleviate
the approximations towards a more principled model.
We proposed the Bayesian flux analysis formalism that considers
fluxes as distributions instead of point estimates. The model learns
a posterior distribution of fluxes given prior information, flux mea-
surements, upper and lower bounds and steady-state assumptions
into account. The degree of belief in the measurements and steady-
state can be adjusted via measurement noise variances and biological
knowledge as encoded in (subjective) priors. The model characterises
the complete space of possible flux configurations by modeling the un-
certainties of fluxes and flux combinations. The Bayesian formalism
can be seen as a drop-in replacement for deterministic flux analysis
tools — such as FBA and FVA — at the cost of added running time
necessary to properly characterise the flux distributions. The runtime
can be effectively alleviated by only considering the core parts of the
metabolic model or by running multiple MCMC chains in parallel.
Our results show that the conventional FBA and FVA tools pro-
vides an overly simplistic view of the flux capabilities of the cellular
system under study, while the Bayesian model expresses the full vari-
ance in the flux configurations. The Bayesian model of metabolism
opens doors for building flux analysis models in a Bayesian way. We
will leave experimental design, knock-outs and strain design using
the Bayesian modelling basis for future work. In future we expect
the Bayesian formalism to provide an alternative statistical approach
for majority of current FBA and MFA based tools with the benefit
of rigorous uncertainty modeling and improved interpretation.
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